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A stable intramolecular complex comprising the LIM domains of the LIM-
homeodomain protein Isl1 tethered to a peptide region of Ldb1 has been
engineered, purified and crystallized. The orthorhombic crystals belonged to
space group P2221, with unit-cell parameters a = 57.2, b = 56.7, c = 179.8 A˚, and
diffracted to 3.10 A˚ resolution.
1. Introduction
The LIM-homeodomain family of transcription factors is responsible
for many cell-fate decisions within developing cells and tissues
(Hunter & Rhodes, 2005). LIM-homeodomain proteins are named
for the pair of N-terminal LIM domains and the centrally located
homeodomain in each family member. They also contain poorly
characterized C-terminal regions. The LIM domains are zinc fingers
that coordinate two zinc ions and mediate protein–protein inter-
actions. The acronym ‘LIM’ is generated from the genes lin-1, isl-1
and mec-3, which were the first in which these domains were identi-
fied (Bach, 2000; Way & Chalfie, 1988; Freyd et al., 1990; Karlsson
et al., 1990). The homeodomains are DNA-binding domains that
specifically target AT-rich sites.
The LIM-homeodomain protein Islet-1 (Isl1) was first isolated as a
binding protein of the rat insulin I gene enhancer sequence (Karlsson
et al., 1990). The protein is critical for many developmental processes.
In the pancreas Isl1 is necessary for the development of pancreatic
mesenchyme and the formation of all endocrine islet cells (Ahlgren
et al., 1997). In the heart, Isl1 is associated with the secondary heart
field. Isl1-expressing cardiac progenitors develop into the outflow
tract, right ventricle and atria in the heart, none of which form in mice
lacking Isl1 (Cai et al., 2003). In the developing central nervous
system Isl1 and its paralogue Isl2 are required to specify motor
neuron cell fate (Pfaff et al., 1996; Thaler et al., 2004). In Isl1/ mice
pituitary development is stalled at the rudimentary stage of Rathke’s
pouch (Takuma et al., 1998).
The biological activity of Isl1 depends on its interaction with
LIM-domain-binding protein 1 (Ldb1), an essential cofactor of
LIM-homeodomain proteins (Matthews & Visvader, 2003). In motor
neurons, Isl1 also binds a second LIM-homeodomain protein, Lhx3,
and the formation of a ternary Ldb1–Isl1–Lhx3 complex is essential
for correct cell-fate determination (Thaler et al., 2002). Isl1 and Lhx3
are also coexpressed in the early stages of Rathke’s pouch formation,
suggesting that the same complex may be required in the pituitary
(Ericson et al., 1998). Within this complex the LIM domains from Isl1
bind to the LIM-interaction domain (LID) of Ldb1 (Ldb1LID), while
the LIM domains from Lhx3 bind to the LID-like Lhx3-binding
domain (LBD) in Isl1 (Isl1LBD) (Fig. 1; Bhati, Lee, Nancarrow, Lee et
al., 2008; Jurata & Gill, 1997). The formation of the ternary complex
appears to be driven, at least in part, by binding to Isl1–Lhx3-specific
recognition sites on DNA, such as those found in the promoter of the
motor neuron-specific gene Hb9 (Bhati, Lee, Nancarrow, Lee et al.,
2008; Thaler et al., 2002; Lee et al., 2008).
We have previously determined the structure of an Lhx3–Isl1LBD
subcomplex of the ternary complex (PDB entry 2rgt; Bhati, Lee,
Nancarrow, Lee et al., 2008) and have determined structures of
related complexes for the LIM domains of the LIM-only protein
LMO4 in complex with Ldb1LID (PDB entry 1rut; Deane et al., 2004),
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Lhx4 in complex with Isl2LBD (PDB entry 3mmk; Gadd et al., 2011)
and the solution structure of Lhx3 in complex with Ldb1LID (PDB
entry 2jtn; Bhati, Lee, Nancarrow, Lee et al., 2008). Others have
determined the structure of a similar complex between LMO2 and
Ldb1LID (El Omari et al., 2011). Here, we report the successful
purification and crystallization of a tethered complex of the LIM
domains of Isl1 and Ldb1LID, which represents the remaining LIM-
containing subcomplex in the ternary complex, and present a preli-
minary analysis of the diffraction data obtained.
2. Methods
2.1. Cloning, expression and purification
A construct containing residues 11–138 of murine Isl1 (NCBI entry
NP_067434), a linker encoding GGSGGHMGSGGG and residues
300–330 of Ldb1 (NCBI entry NP_034827.1) was cloned into a
pGEX-2T vector (GE Healthcare) for expression with an N-terminal
glutathione S-transferase (GST) tag. Protein expression from this
plasmid was carried out in Escherichia coli BL21 (DE3) cells in Luria
broth using 0.4 mM IPTG induction for 20 h at 293 K. Purification
was carried out as described for Lhx4–Isl2 in Gadd et al. (2009). In
brief, cells were lysed by freeze–thawing and sonication and GST–
Isl1–Ldb1 was purified by affinity chromatography using glutathione
Sepharose 4B resin (GE Healthcare). Thrombin was used to remove
the GST tag, leaving two additional residues (GS) at the N-terminus
of Isl1–Ldb1. Size-exclusion chromatography on a HiLoad 16/60
Superdex 200 column (GE Healthcare) was used to further purify the
protein in a buffer composed of 20 mM Tris–HCl pH 8.0, 150 mM
NaCl and 1 mM dithiothreitol. Additionally, the protein was then
passed over glutathione resin once more to remove small amounts
of contaminating GST. The purified protein was concentrated with
centrifugal filtration devices (Vivaspin 6, GE Healthcare) to a
concentration of 10 mg ml1 in the same buffer prior to crystal-
lization. The protein concentration was determined spectrophoto-
metrically from the absorbance at 280 nm (NanoDrop ND-1000
Spectrophotometer, Biolab) using a theoretical extinction coefficient
of 14 440M1 cm1.
2.2. Crystallization
Commercial sparse-matrix crystallization screens (Qiagen) were
used to explore preliminary crystallization conditions. A Mosquito
positive-displacement liquid-handling robot (TTP LabTech) was used
to combine equal volumes (400 nl) of crystallization conditions and
protein solution (10 mg ml1) suspended above well solutions
(75 ml) in hanging-drop 96-well format trays. The trays were incu-
bated at room temperature (293 K). Crystal optimization was
achieved by large-scale hanging-drop experiments in which a total of
4 ml of protein and well solutions were combined in ratios of 1:1–8,
respectively, and equilibrated against 0.5 or 1 ml of well solution at
room temperature.
2.3. Data collection and processing
The crystal was cryoprotected by soaking it in a solution of 20%
2-methyl-2,4-pentanediol/80% well solution prior to flash-cooling in a
nitrogen-gas stream at 100 K. Diffraction data were recorded on the
Australian Synchrotron beamline MX2 with a Quantum 315 CCD
detector (ADSC) using Blu-Ice software (McPhillips et al., 2002). A
fluorescence excitation scan was performed to determine the position
of the zinc edge; however, owing to instrumentation issues the data
were inconclusive and theoretical values were primarily used to
determine wavelengths for data collection. Sequentially, 720 frames
were recorded at a crystal-to-detector distance of 280 mm and a
wavelength of 1.2816 A˚ (zinc peak), 360 frames were recorded at a
crystal-to-detector distance of 400 mm and a wavelength of 0.9537 A˚
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Figure 1
The ternary complex for motor neuron specification. The LIM domains of Isl1 bind
the LID of Ldb1 and the LIM domains of Lhx3 bind the LBD of Isl1 to form the
ternary complex. LID, LIM-interaction domain; LBD, Lhx3-binding domain; SD,
self-association domain; HD, homeodomain.
Figure 2
Orthorhombic crystals of an Isl1–Ldb1 complex after 10 d. The crystals are 100–200 mm in the longest dimension. Observed crystal morphologies include needle clusters (a),
plate clusters (b) and ‘wedge’ clusters (c).
(remote) and 720 frames were recorded at a crystal-to-detector
distance of 280 mm and a wavelength of 1.2826 A˚ (zinc inflection).
The resolution limits for the zinc peak/inflection and remote frames
were 2.53 and 2.56 A˚, respectively. An oscillation range of 0.5 and 1 s
exposure were used for each frame. The diffraction data were inte-
grated and scaled using the HKL-2000 package (Otwinowski &
Minor, 1997).
3. Results and discussion
A complex comprising the LIM domains of Isl1 and Ldb1LID was
generated. When expressed recombinantly, LIM domains from LIM-
homeodomain and LIM-only proteins tend to be insoluble; however,
by tethering the LIM domains to an interacting peptide a stable
complex may be produced (Bhati, Lee, Nancarrow, Bach et al., 2008;
Deane et al., 2001). Thus, the LIM domains of Isl1 were fused, via a
flexible 12-residue linker, to Ldb1LID in that order (Isl1–Ldb1). The
tethered Isl1–Ldb1 complex (19 600 Da) was produced with yields of
3–4 mg protein per litre of medium and >95% purity as determined
by SDS–PAGE with Coomassie staining.
Initial crystallization screening resulted in small crystals after 3–5 d
under one of 864 conditions trialled: Qiagen JCSG+ Suite condition
No. 42 [20%(w/v) polyethylene glycol 8000, 0.2M magnesium
chloride, 0.1M Tris pH 8.5]. Optimization of JCSG+ Suite condition
No. 42 yielded an array of conditions that produced clustered crystals
in a variety of shapes with maximum dimension 200 mm after 1–
2 weeks: 16–24%(w/v) polyethylene glycol 8000, 0.2M magnesium
chloride, 0.1M Tris–HCl pH 8.1–9.1, 1:1–5 protein:well solution
(Fig. 2). No obvious relationships between crystallization conditions
and crystal morphology were observed. Data were recorded from
a single crystal obtained using conditions consisting of 20%(w/v)
polyethylene glycol 8000, 0.2M magnesium chloride, 0.1M Tris–HCl
pH 8.9, 0.3 mM zinc sulfate. The crystal was obtained from a cluster
similar to that in Fig. 2(c) by tapping the common nucleus to separate
the crystals from each other and from the skin of denatured protein
on the surface of the drop.
Diffraction data were recorded as described. The accumulation of
radiation damage was observed during the collection of the ‘zinc
peak’ data (1.2816 A˚). Following data scaling, higher Rmerge values
were calculated when all 720 frames (360) of the data were used
compared with the first 360 frames (180) of the data. Additionally,
the scaling B-factor values increased dramatically between frame 360
(180 total oscillation) and frame 720 (360) (Fig. 3). Because of the
observation of radiation damage in the zinc peak data, the subse-
quent data sets (remote and zinc inflection) were not considered to be
suitable for use in structure determination or refinement.
All 720 frames (360) of the zinc peak data were scaled together
and the resulting data-collection and processing statistics are
summarized in Table 1. The crystals were primitive orthorhombic,
with unit-cell parameters a = 57.2, b= 56.7, c= 179.8 A˚, and diffracted
to 3.10 A˚ resolution (Fig. 4). Based on observed systematic absences
the space group is predicted to be P2221. Three molecules are
predicted within the asymmetric unit, resulting in a corresponding
specific volume of 2.5 A˚3 Da1 and a solvent content of 50.3%
(Matthews, 1968).
We will use the anomalous signal at 1.2816 A˚ to build a heavy-atom
substructure from the 12 Zn atoms in the asymmetric unit. We will
attempt experimental phasing using the complete 720 frames for the
highest possible redundancy of reflections. The observed anomalous
signal [F/(F )] as calculated by SHELXC drops to 0.8 (noise) at
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Figure 3
Scaling B factors plotted against frame number for the zinc peak data set.
Figure 4
Diffraction image of the Isl1–Ldb1 complex. The inset shows visible data at higher
resolution.
Table 1
Data-collection statistics for the zinc peak.
Values in parentheses are for the highest resolution shell.
Wavelength (A˚) 1.2816
Bravais lattice P222
Unit-cell parameters (A˚) a = 57.2, b = 56.7, c = 179.8
Resolution limits (A˚) 50.0–3.10 (3.15–3.10)
Average mosaicity () 0.82
Completeness (%) 100.0 (100.0)
Wilson B factor (A˚2) 60.6
Observed reflections 159125
Unique reflections† 21119
Multiplicity† 7.5 (7.6)
Rmerge‡ 0.156 (0.617)
hI/(I)i 9.4 (2.6)
† Friedel pairs were kept separate for the purposes of scaling. ‡ Rmerge =P
hkl
P
i jIiðhklÞ  hIðhklÞi=
P
hkl
P
i IiðhklÞ.
roughly 4 A˚ resolution (Fig. 5; Sheldrick, 2008). Should the anom-
alous signal prove insufficient, we will endeavour to overcome the
phase problem using molecular replacement (MR) and the available
homologous structures (Bhati, Lee, Nancarrow, Lee et al., 2008;
Deane et al., 2004; El Omari et al., 2011; Gadd et al., 2011). Based
on our previous experience attempting MR on these structures, we
anticipate such an approach to be difficult. We intend to refine any
resulting structure against a smaller scaled data set excluding frames
exhibiting radiation damage.
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Figure 5
Observed anomalous signal [F/(F)] plotted against resolution. The ‘noise’
cutoff of 0.8 is indicated by a dashed line.
